Drug · CHEMBL2
Comparisons in its trials41
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
1 to 20 of 41
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Intervention vs Usual Care: deaths from any cause | 6 of 265 | 3 of 370 | 635 | NCT02655354 | Trial comparisons |
| Intervention vs Usual Care: serious adverse events | 15 of 265 | 13 of 370 | 635 | NCT02655354 | Trial comparisons |
| Prazosin Group vs Placebo Group: serious adverse events | 18 of 152 | 17 of 152 | 304 | NCT00532493 | Trial comparisons |
| 24 Hour Postop Catheter Removal vs 72 Hour Postoperative Catheter Removal: Number of Participants With Acute Urinary Retention | 6 of 71 | 7 of 71 | 142 | NCT01923129 | Trial comparisons |
| 24 Hour Postop Catheter Removal vs 72 Hour Postoperative Catheter Removal: deaths from any cause | 0 of 71 | 0 of 71 | 142 | NCT01923129 | Trial comparisons |
| 24 Hour Postop Catheter Removal vs 72 Hour Postoperative Catheter Removal: Number of Participants With a Symptomatic Urinary Tract Infection | 0 of 71 | 8 of 71 | 142 | NCT01923129 | Trial comparisons |
| 24 Hour Postop Catheter Removal vs 72 Hour Postoperative Catheter Removal: serious adverse events | 0 of 71 | 0 of 71 | 142 | NCT01923129 | Trial comparisons |
| Prazosin 2mg Trials vs Placebo Trials: deaths from any cause | 0 of 64 | 0 of 64 | 128 | NCT02966340 | Trial comparisons |
| Prazosin 2mg Trials vs Placebo Trials: serious adverse events | 0 of 64 | 0 of 64 | 128 | NCT02966340 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 0 of 50 | 0 of 46 | 96 | NCT00744055 | Trial comparisons |
| Prazosin vs Placebo: deaths from any cause | 0 of 48 | 1 of 44 | 92 | NCT00762710 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 3 of 48 | 2 of 44 | 92 | NCT00762710 | Trial comparisons |
| Prazosin vs Placebo: deaths from any cause | 0 of 59 | 0 of 30 | 89 | NCT02965027 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 1 of 59 | 1 of 30 | 89 | NCT02965027 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 0 of 20 | 0 of 20 | 40 | NCT01637584 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 0 of 18 | 0 of 18 | 36 | NCT01916941 | Trial comparisons |
| Treatment (Prazosin) vs Placebo Oral Capsule: deaths from any cause | 0 of 26 | 0 of 8 | 34 | NCT03710642 | Trial comparisons |
| Treatment (Prazosin) vs Placebo Oral Capsule: serious adverse events | 5 of 26 | 0 of 8 | 34 | NCT03710642 | Trial comparisons |
| Prazosin vs Placebo: deaths from any cause | 0 of 14 | 0 of 14 | 28 | NCT01518972 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 0 of 14 | 0 of 14 | 28 | NCT01518972 | Trial comparisons |
pipelines-2026-09-18-0.3.1
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL2/comparisons